Silvia Franceschetti

The coding genome of splenic marginal zone lymphoma: activation of <i>NOTCH2</i> and other pathways regulating marginal zone development

Davide Rossi, Marco Fangazio, Alessio Bruscaggin et al. · The Journal of Experimental Medicine · 2012 · 377 citations · Full text

Lymphocyte Development, Immunology, Pathology +17

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome

Davide Rossi, Michaela Cerri, Daniela Capello et al. · British Journal of Haematology · 2008 · 238 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cd38 Expression +13

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Patrizia Pregno, Annalisa Chiappella, Marilena Bellò et al. · Blood · 2012 · 234 citations

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Andrea Rinaldi, Michael Mian, Ekaterina Chigrinova et al. · Blood · 2010 · 187 citations · Full text

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti et al. · The Lancet Oncology · 2014 · 182 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +9